VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

live attenuated Brucella ovis strain delta abcBA vaccine
Vaccine Information
  • Vaccine Name: live attenuated Brucella ovis strain delta abcBA vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009328
  • Type: Live attenuated vaccine
  • Status: Research
  • Host Species for Licensed Use: Sheep
  • Host Species as Laboratory Animal Model: Mus musculus (BALB/c and C57BL/6 mice)
  • Antigen: abcBA deletion mutant
  • Preparation: The vaccine was formulated as an encapsulated live attenuated ΔabcBA strain; both single and multiple doses were tested, with encapsulation significantly improving protection. (Silva et al, 2015)
  • Description: The study evaluated the Brucella ovis ΔabcBA strain as a vaccine candidate in mice to assess protection against wild-type B. ovis challenge. Efficacy: Single or multiple immunizations with non-encapsulated strain provided mild protection with reduced liver bacterial loads but not spleen; encapsulated vaccine significantly improved protection in both mouse strains and prevented lesions in spleen and liver. (Silva et al, 2015)
Host Response

Mouse Response

  • Vaccination Protocol: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain. (Silva et al, 2015)
  • Challenge Protocol: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain, then challenged with wild-type B. ovis; bacterial counts and lesion development in liver and spleen were assessed. (Silva et al, 2015)
  • Efficacy: Single or multiple immunizations with non-encapsulated strain provided mild protection with reduced liver bacterial loads but not spleen; encapsulated vaccine significantly improved protection in both mouse strains and prevented lesions in spleen and liver. (Silva et al, 2015)
  • Description: BALB/c and C57BL/6 mice were immunized subcutaneously or intraperitoneally with single or multiple doses of the vaccine strain, then challenged with wild-type B. ovis; bacterial counts and lesion development in liver and spleen were assessed. (Silva et al, 2015)
References
Silva et al, 2015: Silva AP, Macêdo AA, Silva TM, Ximenes LC, Brandão HM, Paixão TA, Santos RL. Protection Provided by an Encapsulated Live Attenuated ΔabcBA Strain of Brucella ovis against Experimental Challenge in a Murine Model. Clinical and vaccine immunology : CVI. 2015 Jul; 22(7); 789-97. [PubMed: 25947146].